Emergent BioSolutions Inc - ESG Rating & Company Profile powered by AI
The Sustainability rating for Emergent BioSolutions Inc represents its reporting of the UN SDGs. The report of Emergent BioSolutions Inc leverages data from across the web as well as from available filings by Emergent BioSolutions Inc. Comprehensive Sustainability analysis of Emergent BioSolutions Inc can be accessed by signing in.
Emergent BioSolutions Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.8; made up of an environmental score of 1.1, social score of 5.0 and governance score of 5.0.
3.8
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| ... | ... | ... | |
| 1476 | Philogen SpA | 3.9 | Medium |
| 1476 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd | 3.9 | Medium |
| 1512 | Emergent BioSolutions Inc | 3.8 | Medium |
| 1512 | Ampio Pharmaceuticals Inc | 3.8 | Medium |
| 1512 | Abeona Therapeutics Inc | 3.8 | Medium |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Emergent BioSolutions Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Emergent BioSolutions Inc report the average age of the workforce?
Sign up for free to unlockDoes Emergent BioSolutions Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Emergent BioSolutions Inc offer flexible work?
Sign up for free to unlockDoes Emergent BioSolutions Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Emergent BioSolutions Inc conduct supply chain audits?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Emergent BioSolutions Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose water use targets?
Sign up for free to unlockDoes Emergent BioSolutions Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Emergent BioSolutions Inc have a product recall in the last two years?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Emergent BioSolutions Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Emergent BioSolutions Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose parental leave metrics?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Emergent BioSolutions Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Emergent BioSolutions Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Emergent BioSolutions Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose its waste policy?
Sign up for free to unlockDoes Emergent BioSolutions Inc report according to TCFD requirements?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose energy use targets?
Sign up for free to unlockDoes Emergent BioSolutions Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Emergent BioSolutions Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Emergent BioSolutions Inc
These potential risks are based on the size, segment and geographies of the company.
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, it is developing AP003, a Naloxone multidose nasal spray; AP007, a sustained release Nalmefene injection for treatment of opioid use disorder; AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; COVID-HIG for the treatment of SARS-CoV2; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, the company provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.